Associations Between Opioid Prescribing Patterns and Overdose Among Privately Insured Adolescents
- PMID: 31575622
- PMCID: PMC6856776
- DOI: 10.1542/peds.2018-4070
Associations Between Opioid Prescribing Patterns and Overdose Among Privately Insured Adolescents
Abstract
Objectives: Little is known about the risk for overdose after opioid prescription. We assessed associations between the type of opioid, quantity dispensed, daily dose, and risk for overdose among adolescents who were previously opioid naive.
Methods: Retrospective analysis of 1 146 412 privately insured adolescents ages 11 to 17 years in the United States captured in the Truven MarketScan commercial claims data set from January 2007 to September 2015. Opioid overdose was defined as any emergency department visit, inpatient hospitalization, or outpatient health care visit during which opioid overdose was diagnosed.
Results: Among our cohort, 725 participants (0.06%) experienced an opioid overdose, and the overall rate of overdose events was 28 events per 100 000 observed patient-years. Receiving ≥30 opioid tablets was associated with a 35% increased risk for overdose compared to receiving ≤18 tablets (hazard ratio [HR] = 1.35; 95% confidence interval: 1.05-1.73; P = .02). Daily prescribed opioid dose was not independently associated with an increased risk for overdose. Tramadol exposure was associated with a 2.67-fold increased risk for opioid overdose compared to receiving oxycodone (adjusted HR = 2.67; 95% confidence interval: 1.90-3.75; P < .0001). Adolescents with preexisting mental health conditions demonstrated increased risk for overdose, with HRs ranging from 1.65 (anxiety) to 3.09 (substance use disorders).
Conclusions: One of 1600 (0.06%) previously opioid-naive adolescents who received a prescription for opioids experienced an opioid overdose a median of 1.75 years later that resulted in medical care. Preexisting mental health conditions, use of tramadol, and higher number of dispensed tablets (>30 vs <18) were associated with an increased risk of opioid overdose.
Copyright © 2019 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
References
-
- Curtin SC, Tejada-Vera B, Warmer M. Drug overdose deaths among adolescents aged 15-19 in the United States: 1999-2015. NCHS Data Brief. 2017;(282):1–8 - PubMed
-
- Banerjee S, Roland CL, Willke R, Mardekian J, Garrison LP Jr.. Prevalence of and comorbid health conditions associated with pediatric prescription opioid use in the US. J Pain Palliat Care Pharmacother. 2017;31(3–4):218–227 - PubMed
-
- Bohnert AS, Valenstein M, Bair MJ, et al. . Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–1321 - PubMed
-
- Han B, Compton WM, Blanco C, et al. . Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167(5):293–301 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources